Gadoteridol
Specifications
120066-54-8CAS Number
2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)IUPAC Name
C17H29GdN4O7Chemical Formula
558.7 g/molMolecular Weight
GADOTERIDOL; ProHance; 120066-54-8; Gadolinium-HP-DO3A; Prohance Multipack; DTXSID2048662; GD-HP-DO 3A; SQ-32692; Gd-HPDO3A; Gd-HP-DO3A; Gadolinium-HP-Do 3A; DTXCID5028588; 0199MV609F; NSC-760055; HSDB 7549; SQ 32,692; SQ 32692; CHEBI:31643; gadolinium 2,2',2''-[10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetate; (+-)-(10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-))gadolinium; (10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato)gadolinium; gadolinium 2,2',2''-(10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate; gadolinium HP-DO3A; Gadolinium 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane; GdHPDO3A; Gd-hydroxypropyl-D03A; RefChem:56478; Gadolinium, (1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N1,N4,N7,N10,O1,O4,O7)-; Gadolinium, (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N(sup 1),N(sup 4),N(sup 7),N(sup 10),O(sup 1),O(sup 4),O(sup 7),O(sup 10))-; Gd-HP-D03A; V08CA04; gadolinium 1,4,7-tris(carboxymethyl)-10-(2'-hydroxypropyl)-1,4,7,10-tetraazacyclododecane; gadolinium(3+) ion 2-(4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetate; Gadoteridolum; Gd(DO3A); CAS-120066-54-8; NCGC00182068-02; NCGC00182068-03; Prohance (TN); GADOTERIDOL [MI]; GADOTERIDOL [INN]; GADOTERIDOL [JAN]; Gd(HP-DO3A); GADOTERIDOL [HSDB]; GADOTERIDOL [USAN]; GADOTERIDOL [VANDF]; GADOTERIDOL [MART.]; GADOTERIDOL [USP-RS]; GADOTERIDOL [WHO-DD]; 2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+); Gadoteridol (JAN/USP/INN); SCHEMBL1650466; GADOTERIDOL [ORANGE BOOK]; GADOTERIDOL [USP IMPURITY]; HMS3264D11; HMS5087L05; MOLI001032; GADOTERIDOL [USP MONOGRAPH]; Tox21_113025; Tox21_113128; EBC-27320; Tox21_113025_1; CCG-213206; DB00597; NCGC00182068-04; NS00078663; D01137; F85197; Q5516429; (+/-)-(10-(2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETATO(3-))GADOLINIUM.; gadolinium(III) 2,2',2''-(10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate; GADOLINIUM, (10-(2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETATO(3-)-N1,N4,N7,N10,O1,O4,O7,O10)-Synonyms
Products Containing Gadoteridol
프로핸스주프리필드시린지(가도테리돌)프로핸스주(가도테리돌)PROHANCE 279,3 mg/ml SOLUCION INYECTABLE EN JERINGA PRECARGADAPROHANCE 279,3 mg/ml SOLUCION INYECTABLEPROHANCE 0,5 mmol/mL, solution injectable en seringue pré-rempliePROHANCE 0,5 mmol/mL, solution injectableProhanceGadoteridol - Biophore India Pharmaceuticals Pvt LtdGadoteridol - MSN LaboratoriesGadoteridolGADOTERIDOL
